Moolec Science SA Ordinary Shares Cash Flow Conversion Efficiency
Moolec Science SA Ordinary Shares cash flow conversion efficiency. Based on the latest financial reports, Moolec Science SA Ordinary Shares (MLEC) has a cash flow conversion efficiency ratio of -0.318x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-890.48K) by net assets ($2.80 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Moolec Science SA Ordinary Shares (2021–2025)
Cash flow conversion efficiency of Moolec Science SA Ordinary Shares from 2021 to 2025. This chart illustrates how Moolec Science SA Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MLEC stock price and chart for real-time trading data and today's change.
Moolec Science SA Ordinary Shares Cash Flow Conversion Ratio Explained
Moolec Science SA Ordinary Shares cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Moolec Science SA Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Moolec Science SA Ordinary Shares ranked by their cash flow conversion efficiency. Also see Moolec Science SA Ordinary Shares (MLEC) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DBT SA
PA:ALDBT
|
-0.387x |
|
Kuchai Develop Bhd
KLSE:2186
|
-0.008x |
|
Pond Technologies Holdings Inc
V:POND
|
0.019x |
|
Town Centre Securities PLC
LSE:TOWN
|
0.032x |
|
FRNT Financial Inc
V:FRNT
|
-0.111x |
|
Sangrix Inc.
NASDAQ:SGRX
|
1.157x |
|
Ivory Properties Group Bhd
KLSE:5175
|
0.629x |
|
IO Biotech Inc
NASDAQ:IOBT
|
-20.283x |
Annual Cash Flow Conversion Efficiency for Moolec Science SA Ordinary Shares (2021–2025)
The table below shows the annual cash flow conversion efficiency of Moolec Science SA Ordinary Shares from 2021 to 2025. Review Moolec Science SA Ordinary Shares (MLEC) financial flexibility to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $-82.87 Million | $-24.45 Million | 0.295x | +121.56% |
| 2024-06-30 | $6.82 Million | $-9.33 Million | -1.369x | -84.14% |
| 2023-06-30 | $10.11 Million | $-7.51 Million | -0.743x | -30.31% |
| 2022-06-30 | $1.60 Million | $-915.08K | -0.570x | -868764.64% |
| 2021-06-30 | $134.08 Million | $-8.80K | 0.000x | -- |
About Moolec Science SA Ordinary Shares
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans… Read more